Prentiss Smith & Co’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,124	Closed	-$156K	–	250
2018 Q3	$156K	Buy	1,124 +9	+0.8%	+$1.13K	0.09%	65
2018 Q2	$138K	Sell	1,115 -1,359	-55%	-$159K	0.08%	72
2018 Q1	$276K	Buy	2,474 +2,465	+27,389%	+$295K	0.14%	68
2017 Q4	$1K	Hold	9	–	–	﹤0.01%	295
2017 Q3	$1K	Hold	9	–	–	﹤0.01%	240
2017 Q2	$1K	Sell	9 -391	-98%	-$45.5K	﹤0.01%	247
2017 Q1	$48K	Sell	400 -9	-2%	-$1.16K	0.03%	114
2016 Q4	$50K	Hold	409	–	–	0.03%	117
2016 Q3	$50K	Hold	409	–	–	0.03%	121
2016 Q2	$48K	Sell	409 -14	-3%	-$1.99K	0.03%	121
2016 Q1	$59K	Hold	423	–	–	0.03%	115
2015 Q4	$81K	Buy	423 +23	+6%	+$4.02K	0.04%	103
2015 Q3	$63K	Sell	400 -9	-2%	-$1.64K	0.03%	108
2015 Q2	$74K	Hold	409	–	–	0.04%	108
2015 Q1	$71K	Buy	409 +9	+2%	+$1.63K	0.03%	114
2014 Q4	$74K	Buy	400 +367	+1,112%	+$68K	0.03%	114
2014 Q3	$5K	Hold	33	–	–	﹤0.01%	211
2014 Q2	$5K	Hold	33	–	–	﹤0.01%	213
2014 Q1	$5K	Hold	33	–	–	﹤0.01%	226
2013 Q4	$4K	Buy	+33	New	+$3.96K	﹤0.01%	224